GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
40.78 +0.07  +0.17% NYSE Apr 21, 20:00 Delayed 2m USD

GlaxoSmithKline Free Cash Flow (Quarterly):

3.101B for Dec. 31, 2016
View 4,000+ financial data types
Browse...
View Full Chart

GlaxoSmithKline Free Cash Flow (Quarterly) Chart

Export Data
Save Image
Print Image

GlaxoSmithKline Historical Free Cash Flow (Quarterly) Data

View and export this data going back to 1985. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2016 3.101B
Sept. 30, 2016 1.592B
June 30, 2016 1.090B
March 31, 2016 -166.06M
Dec. 31, 2015 1.261B
Sept. 30, 2015 55.44M
June 30, 2015 -303.21M
March 31, 2015 7.579M
Dec. 31, 2014 2.639B
Sept. 30, 2014 1.408B
June 30, 2014 642.38M
March 31, 2014 956.35M
Dec. 31, 2013 2.693B
Sept. 30, 2013 2.541B
June 30, 2013 1.959B
March 31, 2013 1.445B
Dec. 31, 2012 2.212B
Sept. 30, 2012 -1.068B
June 30, 2012 2.191B
March 31, 2012 1.189B
Dec. 31, 2011 2.674B
Sept. 30, 2011 2.445B
June 30, 2011 1.623B
March 31, 2011 1.150B
Dec. 31, 2010 1.540B
   
Sept. 30, 2010 1.102B
June 30, 2010 2.515B
March 31, 2010 2.801B
Dec. 31, 2009 2.216B
Sept. 30, 2009 3.016B
June 30, 2009 2.178B
March 31, 2009 1.937B
Dec. 31, 2008 2.347B
Sept. 30, 2008 2.433B
June 30, 2008 1.780B
March 31, 2008 2.939B
Dec. 31, 2007 1.492B
Sept. 30, 2007 2.932B
June 30, 2007 1.979B
March 31, 2007 1.646B
Dec. 31, 2006 1.724B
Sept. 30, 2006 -821.97M
June 30, 2006 1.483B
March 31, 2006 2.716B
Dec. 31, 2005 1.346B
Sept. 30, 2005 2.994B
June 30, 2005 2.154B
March 31, 2005 2.195B
Dec. 31, 2004 775.96M
Sept. 30, 2004 2.992B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Free Cash Flow

Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.

According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More

Advertisement

GSK Free Cash Flow (Quarterly) Benchmarks

Companies
AstraZeneca 1.319B
Bristol-Myers Squibb 1.057B
Johnson & Johnson 5.56B

GSK Free Cash Flow (Quarterly) Range, Past 5 Years

Minimum -1.068B Sep 2012
Maximum 3.101B Dec 2016
Average 1.277B

GSK Free Cash Flow (Quarterly) Excel Add-In Codes

  • Metric Code: free_cash_flow
  • Latest data point: =YCP("GSK", "free_cash_flow")
  • Last 5 data points: =YCS("GSK", "free_cash_flow", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.